Prelude Therapeutics
PRLD
#9046
Rank
A$0.10 B
Marketcap
$1.89
Share price
4.58%
Change (1 day)
-58.23%
Change (1 year)

Earnings for Prelude Therapeutics (PRLD)

Earnings in 2024 (TTM): -A$0.22 Billion

According to Prelude Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.2 Billion a decrease over its 2022 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prelude Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.22 Billion7.83%
2023 -A$0.2 Billion7.07%
2022 -A$0.19 Billion8.62%
2021 -A$0.18 Billion93.55%
2020 -A$88.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.19 Billion-12.06%๐Ÿ‡บ๐Ÿ‡ธ USA